Business · 1 sources covering this

Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs

Retatrutide is still in Phase 3 trials, while Lilly says no regulator has approved the experimental obesity drug for human use amid growing black-market sales.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs
Retatrutide is still in Phase 3 trials, while Lilly says no regulator has approved the experimental obesity drug for human use amid growing black-market sales.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/f9a594e5cf3fa657a923a6b4a33ad1b57d875890"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs"></iframe>

Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs

How 1 sources are covering this

Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs

More from Business

Maharashtra FDA suspends licences 4 Domino’s outlets, including 3 in Mumbai, over hygiene violations

Lionel Messi hints at retirement after father’s death, writes open letter, ‘Now, I have serious doubts…’

July household inflation little changed at 4.45%, food prices rise

West Asia conflict may have fiscal implications in FY27: Finance Ministry

Reader

Trust & legal

Across the network